The Expression Level of CB 1 and CB 2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
Eiron Cudaback, William Marrs, Thomas Moeller et al. · 2010
Read The Expression Level of CB 1 and CB 2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas by Eiron Cudaback, William Marrs, Thomas Moeller et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008702.txt.
Description
Eiron Cudaback, William Marrs, Thomas Moeller, and colleagues asked how receptor counts shape a drug effect. Their 2010 PLOS ONE study used astrocytoma cells, a kind of brain tumor. Cannabis compounds can push such tumor cells to die. Two docking sites, CB1 and CB2, catch those compounds. Which site does the work was unsettled.
The researchers built tumor cell lines with set amounts of each receptor. They then dosed the cells and watched for self-destruction, called apoptosis. The balance of CB1 and CB2 decided how strong the killing was. Tumor tests may need receptor counts before cannabis-based treatment makes sense.
Catalog record
| CREATOR | Eiron Cudaback, William Marrs, Thomas Moeller et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008702